Form 4: Merck Executive Betty Larson Reports Stock Transactions
Statement of Changes in Beneficial Ownership
Betty D. Larson, EVP and Chief HR Officer of Merck & Co., Inc., reported transactions involving restricted stock units and stock options.
Summary
- Betty D. Larson, Executive Vice President and Chief Human Resources Officer at Merck & Co., Inc., has reported transactions related to her beneficial ownership of company securities.
- These transactions include the acquisition of restricted stock units (RSUs) and the exercise of stock options.
- The earliest transaction date reported is May 5, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents standard executive compensation and stock option activity rather than significant new financial information or strategic shifts.
Positives
- Betty D. Larson acquired 7,954 restricted stock units, which represent a contingent right to receive shares of Merck & Co., Inc. common stock.
- Betty D. Larson exercised stock options to acquire 23,283 shares of common stock at an exercise price of $113.15 per share.
Future Outlook
The restricted stock units vest and are distributed in three equal installments on May 5, 2027, May 5, 2028, and May 5, 2029. The stock options vest and become exercisable in equal installments on May 5, 2027, May 5, 2028, and May 5, 2029.
Industry Context
StockSavvy.ai notes that this Form 4 filing by a senior executive at Merck & Co., Inc. is a routine disclosure of insider stock transactions, providing transparency into executive compensation and potential personal investment strategies within the pharmaceutical industry.
Stakeholder Impact
- Shareholders: Increased transparency into executive compensation and potential insider investment activity.
Next Steps
- Vesting and distribution of restricted stock units on May 5, 2027, May 5, 2028, and May 5, 2029.
- Vesting and exercisability of stock options on May 5, 2027, May 5, 2028, and May 5, 2029.
Key Dates
| Date | Description |
|---|---|
| 05/05/2026 | Earliest transaction date reported and date of acquisition of restricted stock units and exercise of stock options. |
| 05/05/2027 | First vesting and distribution date for restricted stock units and first vesting date for stock options. |
| 05/04/2036 | Expiration date for stock options. |
| 05/07/2026 | Date the statement was signed. |
Keywords
Form 4, SEC Filing, Merck & Co., Inc., MRK, Betty D. Larson, Stock Options, Restricted Stock Units, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.